Skip to main content

Table 1 Susceptibility of Salmonella , Shigella sp and diarrheagenic Escherichia coli isolated from stools of patients with acute diarrhea, in Madagascar

From: Antimicrobial resistance of bacterial enteropathogens isolated from stools in Madagascar

 

Salmonella sp (n = 84)

Shigella sp(n = 164)

DiarrheagenicE. coli(n = 195)

Antimicrobial

Resistant

Intermediate

Susceptible

Resistant

Intermediate

Susceptible

Resistant

Intermediate

Susceptible

 

N (%)

(%)

(%)

(%)

(%)

(%)

(%)

(%)

(%)

Amoxicillin

30 (35.7)

0 (0.0)

54 (64.3)

103 (62.8)

0 (0.0)

61 (37.2)

160 (82.1)

0 (0.0)

35 (17.9)

Amoxicillin/Clavulanic acid

2 (2.3)

3 (3.6)

79 (94.1)

12 (7.3)

40 (24.4)

112 (68.3)

2 (1.0)

21 (10.8)

172 (88.2)

Ticarcillin

30 (35.7)

0 (0.0)

54 (64.3)

102 (62.2)

1 (0.6)

61 (37.2)

161 (82.6)

0 (0.0)

34 (17.4)

Cephalothin

2 (2.3)

3 (3.6)

79 (94.1)

14 (8.5)

37 (22.5)

113 (69)

6 (3.1)

11 (5.6)

178 (91.3)

Cefotaxime

1 (1.2)

0 (0.0)

83 (98.8)

0 (0.0)

0 (0.0)

164 (100)

6 (3.1)

0 (0.0)

189 (96.9)

Ceftazidime

1 (1.2)

0 (0.0)

83 (98.8)

0 (0.0)

0 (0.0)

164 (100)

3 (1.5)

3 (1.5)

189 (96.9)

Cefoxitin

0 (0.0)

0 (0.0)

84 (100)

0 (0.0)

0 (0.0)

164 (100)

0 (0.0)

1 (0.5)

194 (99.5)

Gentamicin

0 (0.0)

0 (0.0)

84 (100)

0 (0.0)

0 (0.0)

164 (100)

2 (1.0)

0 (0.0)

193 (99.0)

Nalidixic acid

1 (1.2)

2 (2.3)

81 (96.5)

1 (0.7)

0 (0.0)

163 (99.3)

21 (10.8)

0 (0.0)

174 (89.2)

Ciprofloxacin

0 (0.0)

0 (0.0)

84 (100)

0 (0.0)

0 (0.0)

164 (100)

6 (3.1)

0 (0.0)

189 (96.9)

Trimethoprim/Sulfamethoxazole

2 (2.3)

0 (0.0)

82 (97.7)

131 (79.9)

5 (3.0)

28 (17.1)

165 (84.6)

2 (1.0)

28 (14.4)